The release of stored Ca 2ϩ from intracellular compartments via InsP 3 1 receptors (InsP 3 Rs) is a pivotal event in the initiation of Ca 2ϩ signals (1) . The kinetic properties of Ca 2ϩ release through this channel are inherently complex (2, 3) , and additional levels of regulation can occur, for example, through phosphorylation by cAMP-dependent protein kinases, CaM kinase, tyrosine kinases, and protein kinase C or through binding to proteins such as FK506-binding protein or chromogranin (4 -7) . The InsP 3 R is also subject to allosteric regulation by ATP (8 -11) . However, among the many factors that converge on the InsP 3 R to influence Ca 2ϩ release, Ca 2ϩ itself is perhaps the most important regulator of channel open probability.
It is firmly established that Ca 2ϩ can act as a co-agonist along with InsP 3 at the cytosolic face of the InsP 3 R to modulate Ca 2ϩ release (12) (13) (14) (15) (16) . Most studies have examined the Type I InsP 3 R, although properties of the receptor differ somewhat depending on the particular isoform that is expressed (2, (17) (18) (19) . The Type I InsP 3 R possesses a bell-shaped dependence on cytosolic [Ca 2ϩ ], whereby Ca 2ϩ efflux is negligible at very low cytosolic [Ca 2ϩ ], but its activity rises as [Ca 2ϩ ] in the cytoplasm increases (ϳ200 -300 nM), and then again diminishes as [Ca 2ϩ ] reaches high levels (above 1 M). These fundamental observations have been indispensable for explaining the "excitability" of the receptor and have provided a mechanistic framework to account for a number of complex phenomena, ranging from Ca 2ϩ oscillations (20) to the basis for metabolic control of Ca 2ϩ signals via mitochondrial Ca 2ϩ uptake (21) . In contrast, the role of intraluminal Ca 2ϩ in regulating the InsP 3 R appears less clear, and different studies have come to conflicting conclusions on this point (22) (23) (24) (25) (26) (27) (28) . It is obvious that luminal [Ca 2ϩ ] might influence the kinetics of release (as assessed by the cytoplasmic transient) by virtue of changes in thermodynamic driving force for Ca 2ϩ efflux when stores are full versus when they are empty. However, numerous reports have implied that there is an additional stimulatory action of intraluminal [Ca 2ϩ ] on store emptying (16, 29 -33) . The idea that luminal Ca 2ϩ can regulate its own efflux has been proposed to underlie the phenomenon of "quantal" or "incremental" Ca 2ϩ release, whereby a submaximal dose of InsP 3 is able to rapidly release just a portion of the stored Ca 2ϩ (34) . While there is evidence for direct binding of Ca 2ϩ to the InsP 3 R (Type 1) at a luminal site (35) , as well as evidence that luminal Ca 2ϩ can promote a conformation of the InsP 3 R that has increased affinity for InsP 3 (29, 36) , many other studies have disputed the stimulatory action of luminal Ca 2ϩ entirely (27) , and Thrower et al. (11) even provided evidence in a reconstituted bilayer system indicating that the Type 1 InsP 3 R is negatively regulated by high (1 mM) intraluminal [Ca 2ϩ ] in the absence of cytoplasmic ATP. Horne and Meyer (37) have suggested that the regulation by intraluminal [Ca 2ϩ ] is an indirect consequence of positive modulation by cytosolic calcium ions. To further complicate this scenario, intraluminal Ca 2ϩ can also modulate the Ca 2ϩ pump SERCA, which is able to transport Ca 2ϩ more rapidly when stores are empty due to a reduction in thermodynamic gradient for calcium (6, 38, 39) . This mechanism has been proposed previously to contribute to quantal Ca 2ϩ release through the ryanodine receptor (40) and InsP 3 Rdependent pathways (41, 42) . Thus, although it seems that intraluminal Ca 2ϩ may play multiple roles in the regulation of channels and pumps involved in Ca 2ϩ signaling, the exact mechanisms of this modulation still need to be assessed.
One of the difficulties in addressing this issue experimentally has been the lack of methods for precisely manipulating luminal [Ca 2ϩ ] within the store. This is particularly true in intact cells. Ideally, the effects of luminal [Ca 2ϩ ] on the release process would be examined under conditions where cytosolic buffering and cellular Ca 2ϩ handling mechanisms are preserved. Here we have reevaluated this issue in a physiological model system using N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylene diamine (TPEN), a membrane-permeant heavy metal chelator (43) that also has low affinity for Ca 2ϩ . TPEN can be used to elicit rapid and reversible changes in free [Ca 2ϩ ] in internal stores of intact cells without directly altering cytoplasmic [Ca 2ϩ ], InsP 3 receptors, or SERCA pumps (44) . We have combined this tool with direct measurements of free luminal [Ca 2ϩ ] changes using the trapped fluorescent low affinity Ca 2ϩ indicator, mag-fura-2, in intact BHK-21 cells (45) (46) (47) . In this way we were able to assess the actions of luminal reduction of free [Ca 2ϩ ] in single living cells with rapid time resolution. Our experiments also employed conditions of native Ca 2ϩ buffering in the cytosol and did not require perturbation of Ca 2ϩ uptake mechanisms (SERCAs).
Our data show that acutely lowering free [Ca 2ϩ ] within the store with TPEN does indeed attenuate the extent of InsP 3 -induced release. A substantial portion of this action can be accounted for compensatory activities of the SERCA, which is able to more rapidly restore Ca 2ϩ in the compartment when the luminal content is reduced, providing a "brake" on store release. When cytosolic [Ca 2ϩ ] was clamped using the strong Ca 2ϩ buffer BAPTA, the action of lowering luminal [Ca 2ϩ ] was still observed, even in the presence of SERCA inhibitors. Thus we conclude that high luminal Ca 2ϩ does exert a direct stimulatory action on store release.
EXPERIMENTAL PROCEDURES
Cell Culture and Dye Loading-BHK-21 cells (purchased from European Collection of Cell Cultures, Salisbury, UK) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and were maintained in a humidified incubator at 37°C in the presence of 5% C0 2 /95% air. Cells were seeded at low density on glass coverslips and used the following day for microspectrofluorimetric measurements of cytoplasmic or intraorganellar free [Ca 2ϩ ] with fura-2-AM (48) or mag-fura-2-AM (49), respectively. Cells were loaded in tissue culture medium at 37°C for 20 min with fura-2-AM (7 M) or for 35-45 min with mag-fura-2-AM (2-5 M). When cells were preloaded with BAPTA-AM, the chelator was added during the last 20 min of dye loading to ensure cytosolic retention (final concentration: 40 M). Subcultures were prepared by trypsinization and the cells used for not more than 10 passages following receipt from the distributor.
Microspectrofluorimetric Measurements-Coverslips with dye-loaded cells were mounted into a heated metal flow-through perfusion chamber described previously placed on the stage of an inverted microscope (Zeiss IM 35, Oberkochen, Germany) and perfused by gravity feed at a rate of 1.5-2 ml/min. Emitted fluorescence from single cells was measured in response to alternate pulses of excitation light (5-ms duration) at 340 and 380 nm, using a computer-controlled four-place sliding filter holder manufactured in-house. The emitted fluorescence (510 nm) was focused on a photomultiplier tube, amplified, digitally converted, and sampled on an IBM-compatible computer. The filter exchange system and data sampling software were designed by Giuseppe and Antonio Troccoli (Bari, Italy). All measurements were automatically corrected for background. The ratio of emitted light from the two excitation wavelengths (340/380) of fura-2 or mag-fura-2 provide a measure of ionized cytoplasmic [Ca 2ϩ ] (48) Ratio Imaging Experiments-In some experiments, fura-2 and magfura-2 measurements were carried out using a ratio imaging set-up running Metafluor software (Universal Imaging, West Chester, PA). Coverslips with dye-loaded cells were mounted in an open-topped perfusion chamber (Series 20, Warner Instrument Corp, Hamden, CT) and placed on the heated stage of a Nikon TE200 inverted microscope. Cells were excited alternately for 80 ms through a 40ϫ (NA 1.4) oil immersion objective. The 340/380 nm excitation wavelengths were generated by a microprocessor controlled filter wheel (Sutter Instruments) placed in the path of a 100-watt mercury light source. Pairs of fluorescence images (emission collected above 510 nm) were captured by a Hamamatsu ORCA ER CCD camera every 4 s and converted to a ratio image by the Metafluor software.
Cell Permeabilization-As described previously (50, 51), dye-loaded cells were rinsed briefly in a high K ϩ solution (in mM: 125 KCI, 25 NaCI, 0.1 MgCl 2, 10 Hepes, pH 7.20) and then exposed for 2-3 min to an "intracellular buffer" at 37°C (the same solution with free [Ca 2ϩ ] clamped to 170 nM using Ca/EGTA buffers and supplemented with 0.375 mM Na 2 ATP) also containing 5 g/ml digitonin. After plasma membrane permeabilization, cells were continuously superfused with intracellular buffer (without digitonin). Measurements of mag-fura-2 fluorescence were performed as above for intact cells.
Solutions and Materials-Unless otherwise stated, all chemicals were purchased from Farmitalia Carlo Erba (Mílano, Italy), Fluka AG (Buchs, Switzerland) or Sigma. Experiments were performed with a Ringer's solution containing (in mM): 121 NaCl, 2.4 K 2 HPO 4 , 0.4 KH 2 PO 4 . 1.2 CaCl 2 , 1.2 MgCl 2 , 5.5 glucose, 10 Hepes/NaOH, pH 7.40. Bradykinin and ionomycin were from Calbiochem-Novabiochem Corp.; InsP 3 , fura-2-AM, mag-fura-2-AM, TPEN, tBHQ, and BAPTA-AM were obtained from Molecular Probes (Eugene, OR). TPEN was either added to experimental solutions from a 200 mM stock prepared in 100% ethanol, or TPEN crystals were added directly to solutions and stirred for several hours until dissolved. When Me 2 SO or ethanol was used as a solvent, the final solvent concentration never exceeded 0.01 or 0.1%, respectively.
Data Analysis-Responses to Ca 2ϩ mobilizing agonists were compared in the same cell in the presence and absence of agents used to alter [Ca 2ϩ ] within the store (TPEN, tBHQ, etc.). This approach eliminated concerns about the variability of the starting mag-fura-2 ratio, which can differ substantially depending on which system (imaging versus microspectrofluorimetric) was used to collect data. These paired data were assessed for statistical significance using Student's t test. Data are expressed as means Ϯ S.E. with n equal to the number of experimental runs.
RESULTS
The moderate affinity of TPEN for Ca 2ϩ (K d ϳ100 M), and the fact that it is uncharged and membrane permeant in its uncomplexed form, makes this compound particularly suitable for rapidly and reversibly chelating Ca 2ϩ within stores. Due to its low affinity for Ca 2ϩ , TPEN does not influence cytosolic [Ca 2ϩ ]. On the other hand, in compartments where free [Ca 2ϩ ] is comparable with the K d of TPEN (such as the InsP 3 -sensitive internal store) the compound binds Ca 2ϩ and rapidly reduces its free concentration. The opposite happens when the chelator in the medium is washed out. Therefore, by grading the TPEN concentration in the bath, it is possible to cause graded and reversible decreases of the [Ca 2ϩ ] within the lumen of the store (44, 51 (47, 50) . Fig. 1A shows a representative experiment in intact BHK-21 cells loaded with mag-fura-2, where addition of 200 M TPEN to the Ca 2ϩ -free medium (Ca 2ϩ -free solutions were used to ensure that the effective concentration of the membrane-permeant, free form of TPEN remained sufficiently high outside of the cell) resulted in a rapid drop of the mag-fura-2 ratio, indicating a drop in [Ca 2ϩ ] in the stores. This decrease in the ratio amounted to 28.6 Ϯ 4.1% of the decrease in the ratio observed following treatment under control conditions with a maximal dose of bradykinin (BK; 100 nM), a Ca 2ϩ mobilizing agonist in these cells. Thus, this dose of TPEN reduces the free releasable ) was significantly reduced and was on average 57 Ϯ 10% of the control response to BK (p Ͻ 0.01; n ϭ 11).
The Action of TPEN Is Not Due to Heavy Metal Binding or Enhanced Ca
2ϩ Buffering-TPEN avidly chelates intracellular heavy metals such as Zn 2ϩ because of its very high affinity for these cations (43) . Since heavy metals can interfere considerably with fluorescent Ca 2ϩ indicators (52), we performed control experiments using a low dose of TPEN (10 M) to test whether the effects described in Fig. 1 might be attributed to changes in heavy metals rather than intrastore [Ca 2ϩ ]. This lower dose of TPEN would be expected to completely bind any endogenous heavy metals (43, 52) . As shown in Fig. 2A, 10 M TPEN did not produce any detectable change in the mag-fura-2 ratio of intact BHK-21 cells and did not induce any significant change in the response to agonists (n ϭ 6). Similar results (Fig.  2B) were obtained in permeabilized cells stimulated with InsP 3 (n ϭ 5). Moreover, no detectable changes in the fura-2 ratio or the response to bradykinin were observed after addition of this low dose (10 M) of TPEN (n ϭ 11; not shown). These experiments indicate that chelation of heavy metals by TPEN did not interfere with the observed responses in BHK-21 cells.
We considered the possibility that TPEN might somehow alter Ca 2ϩ release by augmenting the buffering capacity for Ca 2ϩ in the store, particularly because the rate of free [Ca 2ϩ ] change in the store during stimulation was very often slower in the presence of 200 M TPEN (see Fig. 1, A and B into the store. Cells were then challenged with agonist, revealing a drop in free Ca 2ϩ that was on average even slightly larger (although not significantly so; 107 Ϯ 4.2%) than that obtained under control conditions in the presence of 0.5 mM added Ca 2ϩ (typical of n ϭ 3 imaging experiments; data from 13 cells). These experiments suggest that the additional Ca 2ϩ buffering introduced by TPEN in the store does not account for the results observed in Fig. 1, A and B .
Effect of 200 M TPEN Is Not Eliminated in the Presence of BAPTA-Acutely lowering the Ca 2ϩ content of the store will reduce the amount of Ca 2ϩ available for release, and attenuate the cytoplasmic spike (refer to Fig. 1C ). The effect of TPEN might therefore be ascribed to a secondary action of reduced Ca 2ϩ at a cytoplasmic site on the InsP 3 R. As shown in Fig. 3 , intact BHK-21 cells were stimulated in the absence and presence of TPEN (200 M), similar to the experiment shown in Fig.  1A . The same cells were then treated for 20 min. on the microscope stage with the high-affinity Ca 2ϩ buffer BAPTA-AM (40 M), which was used to prevent cytoplasmic [Ca 2ϩ ] transients (47) . As shown in Fig. 3 , the response to BK was still strongly reduced (68.2 Ϯ 4.5% of control, p Ͻ 0.01, n ϭ 6) in the presence of TPEN following BAPTA-AM treatment. These data exclude the possibility that cytoplasmic Ca 2ϩ is the only modulator of the release mechanism.
Role of the SERCA Pump in Limiting Ca 2ϩ Release from Stores-Another possible explanation to account for the actions of luminal Ca 2ϩ on the release process relates to the increased efficiency of the SERCA pump to accumulate Ca 2ϩ following luminal depletion. In fact, acute treatment (ϳ1 min) with the SERCA inhibitor tBHQ prior to agonist addition consistently caused a much more profound release of Ca 2ϩ from stores following agonist stimulation, which was 165 Ϯ 14% of control 
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(p Ͻ 0.0005; n ϭ 14; not shown). Similar findings were reported previously by Yu and Hinkle (53) in studies using genetically encoded "cameleon" reporters targeted to the ER lumen in HEK293 cells. One explanation for this enhanced stimulation of release following pump inhibition is that cytoplasmic Ca 2ϩ was elevated, due to the passive leak of Ca 2ϩ out of stores upon SERCA inhibition, causing the InsP 3 receptor to become more "excitable." However, in intact cells pretreated with BAPTA-AM, the extent of release elicited by agonist following tBHQ treatment was also significantly enhanced, amounting to 178 Ϯ 19% of the control release (n ϭ 8; not shown). Moreover, similar results were seen in digitonin-permeabilized cells bathed in an EGTA-containing intracellular-like buffer, where brief pretreatment of cells with tBHQ caused InsP 3 -induced drop in the mag-fura-2 ratio to increase by 157 Ϯ 17% of the control release in the absence of tBHQ (n ϭ 10; not shown).
Combined Effects of TPEN and SERCA Inhibitors-The previous results show that rapid re-accumulation of Ca 2ϩ by ER pumps effectively restricts the net drop in ER [Ca 2ϩ ] following InsP 3 receptor activation. We next examined whether lowering luminal [Ca 2ϩ ] with 200 M TPEN at the same time as the SERCA was inhibited with tBHQ had any effect on the extent of agonist-induced release from internal stores. As shown in Fig. 4 , cells were first treated with 200 m TPEN in Ca 2ϩ -free solutions to lower the free [Ca 2ϩ ] in the store, followed by exposure to 20 M tBHQ for a brief period (ϳ1 min) prior to stimulation with BK. The magnitude of the ratio decrease due to agonist treatment was compared with that obtained in the absence of TPEN, i.e. after a 1-min pretreatment with only tBHQ. Interestingly, we could not detect a significant difference in the ratio decrease following stimulation in the control condition versus that in the presence of 200 M TPEN (although the initial rate of release was significantly slower). Interpretation of these results is complicated by the fact that cytoplasmic [Ca 2ϩ ] will be somewhat elevated following tBHQ treament, due to leakage of Ca 2ϩ out of the stores. However, as described in more detail below, when cells were pretreated with BAPTA-AM, there was a significant difference between the ratio drop with tBHQ alone (control), compared with the drop in the presence of TPEN ϩ tBHQ (82.9 Ϯ 5.6% of control; n ϭ 10). Similar results (not shown) were obtained in digitonin-permeabilized cells, where TPEN addition also significantly attenuated the extent of release elicited by 6 M InsP 3 (TPEN ϩ tBHQ was 70.8 Ϯ 4.0% of the control with tBHQ alone, p ϭ 0.02; n ϭ 8).
The experiment shown in Fig. 5 summarizes our main findings. Intact mag-fura-2-loaded cells were pretreated with BAPTA-AM. Cells were first stimulated with agonist in the presence of tBHQ and 200 M TPEN. The extent of this release was smaller than that observed when cells were stimulated following tBHQ treatment alone, indicating that luminal [Ca 2ϩ ] modulates efflux independent of effects on the SERCA pump when cytosolic [Ca 2ϩ ] has been clamped with BAPTA-AM. When SERCA pumps were functional, the extent of release was much smaller (both in the presence and absence of TPEN) showing that Ca 2ϩ sequestration has a powerful braking effect on the release process. The main point, however, is that the combined treatment of BAPTA-AM, tBHQ, and TPEN still resulted in an additional attenuation of Ca 2ϩ efflux, indicating that luminal Ca 2ϩ affects release by some additional mechanism that is independent of SERCA activity or cytoplasmic Ca In this work we used a new tool for manipulating free [Ca 2ϩ ] within the lumen of the agonist-sensitive store (TPEN 45 Ca 2ϩ measurements in permeabilized cell populations, this method also affords rapid time resolution in single intact cells, which is important since the rapid phase of the InsP 3 -induced release process is nearly complete within 60 s of stimulation.
Apart from potentially providing insight into the mechanisms underlying the quantal Ca 2ϩ release phenomenon and the coupling between the filling state of stores and capacitative entry, our studies also highlight the importance of store loading in determining the magnitude of the cytosolic Ca 2ϩ signal following agonist stimulation. Calcium ions within stores have numerous regulatory roles (56), but until recently there has been little appreciation of conditions (physiological or pathological) whereby the filling state of the stores might become altered. For example, studies by Leissring et al. (57) have demonstrated that expression of the mutated form of Presenilin-1, a resident ER protein implicated in the pathogenesis of Alzheimer's disease, results in an increase in ER Ca 2ϩ content. This overfilling of stores led to significant downstream defects in Ca 2ϩ signaling, including heightened cytoplasmic spikes and attenuated Ca 2ϩ entry at the plasma membrane. Further recent data suggest that intraluminal ER [Ca 2ϩ ] may serve as a control point for apoptosis (58) . Several groups have now shown that expression of the anti-apoptotic protein bcl-2 can lower [Ca 2ϩ ] within the lumen of the ER, perhaps by creating a passive leak of Ca 2ϩ out of this compartment that alters the resting steady state level of the cation (59, 60) .
Our experiments demonstrate that a reduction in the free [Ca 2ϩ ] within the store attenuates Ca 2ϩ release into the cytoplasm of intact cells, beyond that which is expected due to simple reduction of the store content. Thus, subtle changes in the resting free [Ca 2ϩ ] within the ER that occur, for example, during apoptosis, may be amplified at the level of the cytoplasm, manifested as highly attenuated Ca 2ϩ signals that ultimately influence key cellular functions governed by calcium signaling cascades.
